Lilly in Europe

Lilly is a biopharmaceutical company with over 38,000 employees worldwide and around 8,500 in Europe. Founded over 140 years ago and established in Europe in 1934, our pioneering medical breakthroughs through the years include the first commercially available human insulin and the polio vaccine.

Our researchers are currently seeking breakthrough therapies in Diabetes, Oncology, Immunology, Neurodegeneration and Pain. Approximately 22% of our sales are reinvested into research and development globally.

Lilly’s commercial activities span the whole of Europe, and in addition, we have a considerable R&D and manufacturing presence located across six sites in Europe, as well as 10 beyond.